Eris Lifesciences Ltd.

855.75 +2.60 ▲0.3%

21 February 2024, 04:12:34 PM
Volume: 114,109

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.eris.co.in
Market Cap 11,635.18 Cr.
Enterprise Value(EV) 12,245.67 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 28.41 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 30.11 Trailing Twelve Months Ending 2023-12
Industry PE 41.82 Trailing Twelve Months Ending 2023-12
Book Value / Share 184.74 Trailing Twelve Months Ending 2023-12
Price to Book Value 4.63 Calculated using Price: 855.35
Dividend Yield 0.86 Period Ending 2023-03
No. of Shares Subscribed 13.60 Cr. 136,028,280 Shares
FaceValue 1
About Eris Lifesciences Ltd.
The company develops, manufactures and commercializes branded pharmaceutical products in select therapeutic areas within the chronic and acute categories of the IPM, such as: cardiovascular; anti-diabetics; vitamins; gastroenterology; and anti-infectives. Its focus has been on developing products in the chronic and acute category which are linked to lifestyle related disorders.

Eris Lifesciences Ltd. Delivery

Delivered Qty
Traded Qty

Eris Lifesciences Ltd. Performance

1 Day
+0.30%
1 Week
-7.37%
1 Month
-4.11%
3 Month
-6.68%
6 Month
+3.07%
1 Year
+34.13%
2 Year
+21.81%
5 Year
+36.99%
10 Year

Eris Lifesciences Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 40.3 47.68 56.9 41.3 28.96 24.28 24.78 23.33 18.25
Return on Capital Employed (%) 49.25 54.56 62.56 35.76 26.54 25.44 27.6 25.29 17.31
Return on Assets (%) 28.59 36.17 43.89 27.31 20.02 20.33 22.62 21.27 13.4

Eris Lifesciences Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 266 300 567 861 1,151 1,296 1,576 1,908 2,196 2,412
Non Curr. Liab. 19 20 12 248 -66 -80 -109 -79 729 655
Curr. Liab. 65 69 129 294 377 220 235 283 521 497
Minority Int. 4 3 24 25 18 0 25 16
Equity & Liab. 354 392 732 1,428 1,481 1,437 1,703 2,113 3,471 3,580
Non Curr. Assets 191 169 463 1,061 827 902 1,167 1,402 2,629 2,619
Curr. Assets 163 222 270 367 653 535 536 711 843 961
Misc. Exp. not W/O
Total Assets 354 392 732 1,428 1,481 1,437 1,703 2,113 3,471 3,580

Eris Lifesciences Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 546 597 750 856 982 1,074 1,212 1,347 1,685 1,861
Other Income 3 3 25 26 32 16 9 26 11 10
Total Income 549 600 775 882 1,014 1,090 1,221 1,373 1,696 1,871
Total Expenditure -424 -425 -480 -533 -637 -706 -781 -862 -1,148 -1,216
PBIDT 125 175 294 349 377 384 439 511 548 655
Interest 0 0 -1 -11 -23 -2 -2 -4 -26 -61
Depreciation -16 -20 -23 -26 -36 -50 -43 -65 -117 -164
Taxation -20 -20 -24 -17 -26 -35 -39 -36 -30 -52
Exceptional Items
PAT 89 135 247 295 291 297 355 406 374 379
Minority Interest 0 -1 0 -1 0 0 0 8 8
Share Associate
Other Related Items
Consolidated Net Profit 89 134 247 294 291 297 355 406 382 386
Adjusted EPS 6 10 18 21 21 22 26 30 28 28

Eris Lifesciences Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 90 90 131 200 235 223 271 375 378 292
Cash Fr. Inv. -83 -92 -44 -184 -590 -5 123 -323 -320 -982
Cash Fr. Finan. -2 0 -84 -24 363 -221 -335 -82 -45 688
Net Change 5 -2 4 -8 8 -3 60 -30 14 -2
Cash & Cash Eqvt 7 5 9 2 11 8 67 37 51 56

Eris Lifesciences Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 52.66 52.66 52.30 52.29 52.70 52.86 52.86 54.91 54.90
Public 47.34 47.34 47.70 47.71 47.30 47.14 47.14 45.09 45.10
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 11.37 10.95 10.95

Eris Lifesciences Ltd. Announcements

Tue, 20 Feb 2024
Analysts/Institutional Investor Meet/Con. Call Updates
Eris Lifesciences Limited has informed the Exchange about Transcript
Thu, 15 Feb 2024
Acquisition-XBRL
Eris Lifesciences Limited has informed the Exchange regarding Acquisition
Thu, 15 Feb 2024
Updates
Eris Lifesciences Limited has informed the Exchange regarding 'closure of acquisition'.

Eris Lifesciences Ltd. Technical Scans

Wed, 21 Feb 2024
Opening at Low Opening at Low
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Below Last Month Low Close Below Last Month Low
Making Lower Lows for 2 Days Making Lower Lows for 2 Days

Eris Lifesciences Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 370,313.36 1,543.40 +0.3%
Cipla Ltd. 116,866.14 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. 105,898.11 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. 97,179.74 6,760.15 +0.0%
Divi's Laboratories Ltd. 96,854.88 3,649.10 -1.7%
Zydus Lifesciences Ltd. 90,440.44 893.80 -0.2%
Torrent Pharmaceuticals Ltd. 88,043.20 2,603.00 -1.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.58 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-12 31.52 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.26 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.12 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 70.03 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-12 30.41 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 58.93 2,603.00 -1.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.94 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-12 4.51 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.94 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.39 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.43 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.65 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.31 2,603.00 -1.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,603.00 -1.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,603.00 -1.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,603.00 -1.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,603.00 -1.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,603.00 -1.6%

Eris Lifesciences Ltd. FAQ's

What is Eris Lifesciences share price?

Can I buy Eris Lifesciences shares now?

What is the Dividend Yield of Eris Lifesciences?

What is the Market Cap of Eris Lifesciences?

What are the key metrics to analyse Eris Lifesciences?

What is the 52 Week High and Low of Eris Lifesciences?

What is the trend of Eris Lifesciences share price?